UOC
TRIL

UBS O'Connor’s Trillium Therapeutics Inc. TRIL Stock Holding History

UBS O'Connor’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,300,000
Closed -$40.4M – 1129
2021
Q3 		$40.4M Buy
+2,300,000
New +$40.4M 0.32% 26